News
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Amgen Inc. (NASDAQ:AMGN) ranks among the best set-it-and-forget-it stocks to buy. On June 24, Piper Sandler reaffirmed its ...
Amgen Inc. (NASDAQ:AMGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. On June 23, the company ...
2d
Woman's World on MSNNew GLP-1 Called MariTide Shows 20% Weight Loss-Without a PlateauIn the same way weight varies from person to person, so do the best weight loss strategies. While some people succeed with ...
Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...
Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with significant health benefits.
Apple (NASDAQ: AAPL) and Amgen (NASDAQ: AMGN), two well-established companies that are part of the iconic Dow Jones ...
US biotech major Amgen, a late comer to the growing obesity treatment space, released new data showing that its MariTide ...
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...
7d
Zacks Investment Research on MSNAmgen Looks to Take Share of Booming Obesity Space: Will It Succeed?Amgen AMGN is one of the several drug makers racing to develop the next blockbuster weight loss drug and take a share of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results